Masahiro Onuma has expertise in oxidative disease
prevention to use non-medical product based on GSK’s experience of Allopurinol
which is the strongest anti-oxidant efficacy in this world. He creates new
indication of Allopurinol for stomatitis induced by cancer treatment which was
approved by the Japanese Cancer treatment committee to propose new mechanism of
Allopurinol for anti-oxidant. And now, there are so many new research papers of
Allopurinol in the world.